The U.S. Food & Drug Administration (FDA) recently “authorized the emergency use of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 through 17 years of age.” On …
Recent FDA Action & Publication Concerning COVID-19 Read more »
Recently, the U.S. Department of Health and Human Services (HHS), Department of Labor (DoL), and Department of the Treasury jointly issued guidance clarifying “protections for birth control coverage under the Affordable Care Act (ACA, Pub. L. 111-148).” Announcing the guidance, …
Recent HHS, Labor and Treasury Departments Guidance on ACA Birth Control Coverage Read more »
Part of the 7/8/2022 Executive Order 14076 – Protecting Access to Reproductive Healthcare Services – required the U.S. Federal Trade Commission (FTC) to consider actions “to protect consumers’ privacy when seeking information about the provision of reproductive healthcare services.” On …
Recent FTC Commitment on Protecting Consumers’ Health Privacy Read more »
Following the 6/24/2022 Dobbs v. Jackson Women’s Health Organization U.S. Supreme Court decision, the U.S. Department of Health and Human Services (HHS) initiated a 5-step action plan that prioritizes “increasing access to medication abortion; protecting patients and providers from discrimination …
Recent HHS Actions on Access to Reproductive Healthcare Services Read more »
On 7/8/2022, U.S. President Joseph R. Biden signed Executive Order 14076 – Protecting Access to Reproductive Healthcare Services. The Executive Order instructs the Secretary of Health and Human Services (HHS) within 30 days to submit a report identifying: potential actions …
Executive Order on Protecting Access to Reproductive Healthcare Services Read more »
